Imaging of lung cancer with fluorine-18 fluorodeoxyglucose: Comparison of a dual-head gamma camera in coincidence mode with a full-ring positron emission tomography system

European Journal of Nuclear Medicine

Volumn 26, Issue 4, 1999, Pages 388-395

  Weber, W A ^a   Neverve, J ^b   Sklarek, J ^b   Ziegler, S I ^b   Bartenstein, P ^b   King, B ^b   Treumann, T ^b   Enterrottacher, A ^b   Krapf, M ^b   Haussinger K E ^b   Lichte, H ^b   Prauer H W ^b   Thetter, O ^b   Schwaiger, M ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

Dual detector coincidence imaging; Fluorodeoxyglucose; Lung cancer; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER SCINTISCANNING; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG CANCER; LUNG METASTASIS; LUNG NODULE; LYMPH NODE METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; SCINTILLATION CAMERA;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; GAMMA CAMERAS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032945147     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050402     Document Type: Article

References (32)

1. 1. Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jerusalem G, Benoit T, Foidart WJ. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996; 23: 1641-1674.
2. 2. Kubota K, Matsuzawa T, Fujiwara T, Ito M, Hatazawa J, Ishiwata K, Iwata R, Ido T. Differential diagnosis of lung tumour with positron emission tomography: a prospective study. J Nucl Med 1990; 31: 1927-1932.
3. 3. Patz EF, Lowe VJ, Hoffman JM, Paine SS, Burrowes P, Coleman RE, Goodman PC. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993; 188: 487-490.
4. 4. Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med 1996; 37: 943-948.
5. 5. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994; 191: 371-377.
6. 6. Steinert HC, Hauser M, Allemann F, Engel H, Berthold T, von Schulthess GK, Weder W. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997; 202: 441-446.
7. 18F]fluorodeoxyglucose. The Members of the PET-Lung Tumor Study Group. Ann Thorac Surg 1994; 58: 698-703.
8. 8. Lowe VJ, Fletcher JW, Gobar L, Lawson M, Kirchner P, Valk P, Karis J, Hubner K, Delbeke D, Heiberg EV, Patz EF, Coleman RE. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 1998; 16: 1075-1084.
9. 9. Ziegler SI, Enterrottacher A, Boning G, Schwaiger M. Performance characteristics of a dual head coincidence camera for the detection of small lesions [abstract]. J Nucl Med 1997; 38: 206.
10. 10. Shreve P, Steventon R, Deters E, Kison P, Gross M, Wahl M. Oncological diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual head coincidence gamma camera versus positron emission tomographic scanner. Radiology 1998; 207: 431-437.
11. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27: 235-238.
12. 12. Wienhard K, Dahlbom M, Eriksson L, Michel C, Bruckbauer T, Pietrzyk U, Heiss WD. The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr 1994; 18: 110-118.
13. 13. Fessler J. Penalized weighted least-squares image reconstruction for positron emission tomography. IEEE Trans Med Imaging 1994; 13: 290-300.
14. 14. Hudson H, Larkin R. Accelerated image reconstructiion using ordered subsets of projection data. IEEE Trans Med Imaging 1994; 13: 601-609.
15. 15. Mountain C. Revisions of the international system for staging lung cancer. Chest 1997; 111: 1710-1717.
16. 16. McLoud T, Bourgouin P, Grenberg R, Kosiuk J, Templeton P, Shepard J-A, Moore E, Wain J, Mathisen D, Grillo H. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182: 319-323.
17. 17. Lewis J, Pearlberg J, Beute G, Alpern M, Kvale P, Gross B, Magilligan D. Can computed tomography of the chest stage lung cancer? - Yes and no. Ann Thorac Surg 1990; 49: 591-596.
18. 18. Kiyono K, Sone S, Sakai F, Ima Y, Watanabe T, Izuno I, Oguchi M, Kawai T, Shitematsu H, Watanabe M. The number and size of normal mediastinal lymph nodes: a postmortem study. AJR Am J Roentgenol 1988; 150: 771-776.
19. 19. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991; 32: 623-648; discussion 649-650.
20. 20. Scott WJ, Gobar LS, Terry JD, Dewan NA, Sunderland JJ. Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg 1996; 111: 642-648.
21. 21. Sazon DA, Santiago SM, Soo HGW, Khonsary A, Brown C, Mandelkern M, Blahd W, Williams AJ. Fluorodeoxyglucosepositron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med 1996; 153: 417-421.
22. 22. Llacer J, Veklerov E, Baxter LR, Grafton ST, Griffeth LK, Hawkins RA, Hoh CK, Mazziotta JC, Hoffman EJ, Metz CE. Results of a clinical receiver operating characteristic study comparing filtered backprojection and maximum likelihood estimator images in FDG PET studies. J Nucl Med 1993; 34: 1198-1203.
23. 23. Becker S, Ziegler S, Weber W, Römer W, Avril N, Schwaiger M. Iterative reconstruction of FDG-PET data: diagnostic value compared to filtered backprojection. J Nucl Med 1997; 101P.
24. 24. Wienhard K, Eriksson L, Grootoonk S, Casey M, Pietrzyk U, Heiss WD. Performance evaluation of the positron scanner ECAT EXACT. J Comput Assist Tomogr 1992; 16: 804-813.
25. 25. Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Bogaert J, Maes A, Deneffe GJ, Nackaerts KL, Verschakelen JA, Lerut TE, Mortelmans LA, Demedts MG. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 1998; 16: 2142-2149.
26. 26. Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Chest 1993; 104: 997-1002.
27. 27. Lowe VJ, Hoffman JM, DeLong DM, Patz EF, Coleman RE. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994; 35: 1771-1776.
28. 28. Praeuer HW, Weber WA, Roemer W, Treumann T, Ziegler SI, Schwaiger M. Controlled prospective study of positron emission tomography using the glucose analogue F-18-fluorodeoxglucose in the evaluation of pulmonary nodules. Br J Surg 1998; 85: 1506-1511.
29. 29. Shao L, Nelleman P, Muehllehner G, Bertelsen H, Hines H. Singles-transmission attenuation correction for dual head coincidence imaging. J Nucl Med 1998; 37: 37P.
30. 30. Bedigian M, Benard F, Smith R, Karp J, Alavi A. Whole-body positron emission tomography for oncology imaging using singles transmission scanning with segmentation and ordered sub-sets-expectation maximization (OS-EM) reconstruction. Eur J Nucl Med 1998; 25: 659-661.
31. 31. Bengel FM, Ziegler SI, Avril N, Weber W, Laubenbacher C, Schwaiger M. Whole-body positron emission tomography in clinical oncology: comparison between attenuation-corrected and uncorrected images. Eur J Nucl Med 1997; 24: 1091-1098.
32. 32. Imran B, Kubota K, Yamada S, Fukuda H, Ymada K, Fujiwara T, Itoh M. Lesion-to-background ratio in nonattenuation-corrected whole-body FDG PET images. J Nucl Med 1998; 39: 1219-1223.